BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6969281)

  • 21. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic levels in infected and sterile subcutaneous abscesses in mice.
    Joiner KA; Lowe BR; Dzink JL; Bartlett JG
    J Infect Dis; 1981 Mar; 143(3):487-94. PubMed ID: 6453169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin.
    Bryant RE; Mazza JA
    Am J Med; 1989 Nov; 87(5A):23S-27S. PubMed ID: 2589367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
    Bach VT; Thadepalli H
    Chemotherapy; 1980; 26(5):344-53. PubMed ID: 6446448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.
    Jarlier V; Gutmann L; Nikaido H
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1937-9. PubMed ID: 1952873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of penicillin by purulent exudates.
    de Louvois J; Hurley R
    Br Med J; 1977 Apr; 1(6067):998-1000. PubMed ID: 585339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis.
    Ferreira MC; Domingues RM; de Uzeda M
    J Antimicrob Chemother; 1989 Aug; 24(2):157-64. PubMed ID: 2793640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP; Nasu M; Williams JD
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbenicillin for treatment of Bacteroides fragilis infections: why not penicillin G?
    Maki DG; Kurzynski TA; Agger WA
    J Infect Dis; 1978 Dec; 138(6):859-64. PubMed ID: 253006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
    Réjiba S; Kechrid A
    J Chemother; 2007 Aug; 19(4):382-7. PubMed ID: 17855181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to cefazedone and cefazolin and production of beta-lactamase in in Bacteroides fragilis and other species of Bacteroidaceae.
    Werner H; Krasemann C; Ungerechts J
    Arzneimittelforschung; 1979; 29(2a):388-92. PubMed ID: 314805
    [No Abstract]   [Full Text] [Related]  

  • 36. AmpC beta-lactamase producing bacterial isolates from Kolkata hospital.
    Arora S; Bal M
    Indian J Med Res; 2005 Sep; 122(3):224-33. PubMed ID: 16251779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new method for evaluation of beta-lactamase production of resistant enterobacteriaceae strains (author's transl)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1978; 242(3):347-54. PubMed ID: 371259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial drugs used in the management of anaerobic infections in children.
    Brook I
    Drugs; 1983 Dec; 26(6):520-9. PubMed ID: 6360636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative susceptibility of cefminox and cefoxitin to beta-lactamases of Bacteroides spp.
    Soriano F; Edwards R; Greenwood D
    J Antimicrob Chemother; 1991 Jul; 28(1):55-60. PubMed ID: 1769943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
    Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA
    J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.